Authors: Abel, S Beaumont, KC Crespi, CL Eve, MD Fox, L Hyland, R Jones, BC Muirhead, GJ Smith, DA Venn, RF Walker, DK

Citation: S. Abel et al., Potential role for P-glycoprotein in the nonproportional pharmacokinetics of UK-343,664 in man, XENOBIOTICA, 31(8-9), 2001, pp. 665-676

Authors: Gage, R Venn, RF Bayliss, MAJ Edgington, AM Roffey, SJ Sorrell, B

Citation: R. Gage et al., Fluorescence determination of sulphobutylether-beta-cyclodextrin in human plasma by size exclusion chromatography with inclusion complex formation, J PHARM B, 22(5), 2000, pp. 773-780

Authors: Bayliss, MAJ Gage, R Edgington, AM Venn, RF

Citation: Maj. Bayliss et al., Fluorescence determination of sulphobutylether-beta-cyclodextrin sodium inhuman plasma and urine by size-exclusion chromatography with inclusion complex formation, CHROMATOGR, 52, 2000, pp. S83-S86

Authors: Saunders, KC Venn, RF Fane, JA

Citation: Kc. Saunders et al., Analysis of CP-122,288 at femto-molar levels from human plasma using solid-supported extraction and HPLC column switching, CHROMATOGR, 52, 2000, pp. S87-S91

Authors: Venn, RF Goody, RJ

Citation: Rf. Venn et Rj. Goody, Synthesis and properties of molecular imprints of darifenacin: The potential of molecular imprinting for bioanalysis, CHROMATOGR, 50(7-8), 1999, pp. 407-414